Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil. / Graversen, Carina; Malver, Lasse P; Kurita, Geana P; Staahl, Camilla; Christrup, Lona Louring; Sjøgren, Per; Drewes, Asbjørn M.

In: Basic & Clinical Pharmacology & Toxicology, Vol. 116, No. 5, 05.2015, p. 414-422.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Graversen, C, Malver, LP, Kurita, GP, Staahl, C, Christrup, LL, Sjøgren, P & Drewes, AM 2015, 'Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil', Basic & Clinical Pharmacology & Toxicology, vol. 116, no. 5, pp. 414-422. https://doi.org/10.1111/bcpt.12330

APA

Graversen, C., Malver, L. P., Kurita, G. P., Staahl, C., Christrup, L. L., Sjøgren, P., & Drewes, A. M. (2015). Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil. Basic & Clinical Pharmacology & Toxicology, 116(5), 414-422. https://doi.org/10.1111/bcpt.12330

Vancouver

Graversen C, Malver LP, Kurita GP, Staahl C, Christrup LL, Sjøgren P et al. Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil. Basic & Clinical Pharmacology & Toxicology. 2015 May;116(5):414-422. https://doi.org/10.1111/bcpt.12330

Author

Graversen, Carina ; Malver, Lasse P ; Kurita, Geana P ; Staahl, Camilla ; Christrup, Lona Louring ; Sjøgren, Per ; Drewes, Asbjørn M. / Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil. In: Basic & Clinical Pharmacology & Toxicology. 2015 ; Vol. 116, No. 5. pp. 414-422.

Bibtex

@article{a79e7abd6c33418584cd461f88ba3173,
title = "Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil",
abstract = "Opioids alter resting state brain oscillations by multiple and complex factors, which are still to be elucidated. To increase our knowledge, multi-channel electroencephalography (EEG) was subjected to multivariate pattern analysis (MVPA), to identify the most descriptive frequency bands and scalp locations altered by remifentanil in healthy volunteers. Sixty-two channels of resting EEG followed by independent measures of pain scores to heat and bone pain were recorded in 21 healthy males before and during remifentanil infusion in a placebo-controlled, double-blind crossover study. EEG frequency distributions were extracted by a continuous wavelet transform and normalized into delta, theta, alpha, beta and gamma bands. Alterations relative to pre-treatment responses were calculated for all channels and used as input to the MVPA. Compared to placebo, remifentanil increased the delta band and decreased the theta and alpha band oscillations as a mean over all channels (all p ≤ 0.007). The most discriminative channels in these frequency bands were F1 in delta (83.33%, p = 0.0023) and theta bands (95.24%, p < 0.0001), and C6 in the alpha band (80.95%, p = 0.0054). These alterations were correlated to individual changes in heat pain in the delta (p = 0.045), theta (p = 0.038) and alpha (p = 0.039) bands and to bone pain in the alpha band (p = 0.0092). Hence, MVPA of multi-channel EEG was able to identify frequency bands and corresponding channels most sensitive to altered brain activity during remifentanil treatment. As the EEG alterations were correlated to the analgesic effect, the approach may prove to be a novel methodology for monitoring individual efficacy to opioids.",
author = "Carina Graversen and Malver, {Lasse P} and Kurita, {Geana P} and Camilla Staahl and Christrup, {Lona Louring} and Per Sj{\o}gren and Drewes, {Asbj{\o}rn M}",
note = "{\textcopyright} 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).",
year = "2015",
month = may,
doi = "10.1111/bcpt.12330",
language = "English",
volume = "116",
pages = "414--422",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Altered Frequency Distribution in the Electroencephalogram is Correlated to the Analgesic Effect of Remifentanil

AU - Graversen, Carina

AU - Malver, Lasse P

AU - Kurita, Geana P

AU - Staahl, Camilla

AU - Christrup, Lona Louring

AU - Sjøgren, Per

AU - Drewes, Asbjørn M

N1 - © 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

PY - 2015/5

Y1 - 2015/5

N2 - Opioids alter resting state brain oscillations by multiple and complex factors, which are still to be elucidated. To increase our knowledge, multi-channel electroencephalography (EEG) was subjected to multivariate pattern analysis (MVPA), to identify the most descriptive frequency bands and scalp locations altered by remifentanil in healthy volunteers. Sixty-two channels of resting EEG followed by independent measures of pain scores to heat and bone pain were recorded in 21 healthy males before and during remifentanil infusion in a placebo-controlled, double-blind crossover study. EEG frequency distributions were extracted by a continuous wavelet transform and normalized into delta, theta, alpha, beta and gamma bands. Alterations relative to pre-treatment responses were calculated for all channels and used as input to the MVPA. Compared to placebo, remifentanil increased the delta band and decreased the theta and alpha band oscillations as a mean over all channels (all p ≤ 0.007). The most discriminative channels in these frequency bands were F1 in delta (83.33%, p = 0.0023) and theta bands (95.24%, p < 0.0001), and C6 in the alpha band (80.95%, p = 0.0054). These alterations were correlated to individual changes in heat pain in the delta (p = 0.045), theta (p = 0.038) and alpha (p = 0.039) bands and to bone pain in the alpha band (p = 0.0092). Hence, MVPA of multi-channel EEG was able to identify frequency bands and corresponding channels most sensitive to altered brain activity during remifentanil treatment. As the EEG alterations were correlated to the analgesic effect, the approach may prove to be a novel methodology for monitoring individual efficacy to opioids.

AB - Opioids alter resting state brain oscillations by multiple and complex factors, which are still to be elucidated. To increase our knowledge, multi-channel electroencephalography (EEG) was subjected to multivariate pattern analysis (MVPA), to identify the most descriptive frequency bands and scalp locations altered by remifentanil in healthy volunteers. Sixty-two channels of resting EEG followed by independent measures of pain scores to heat and bone pain were recorded in 21 healthy males before and during remifentanil infusion in a placebo-controlled, double-blind crossover study. EEG frequency distributions were extracted by a continuous wavelet transform and normalized into delta, theta, alpha, beta and gamma bands. Alterations relative to pre-treatment responses were calculated for all channels and used as input to the MVPA. Compared to placebo, remifentanil increased the delta band and decreased the theta and alpha band oscillations as a mean over all channels (all p ≤ 0.007). The most discriminative channels in these frequency bands were F1 in delta (83.33%, p = 0.0023) and theta bands (95.24%, p < 0.0001), and C6 in the alpha band (80.95%, p = 0.0054). These alterations were correlated to individual changes in heat pain in the delta (p = 0.045), theta (p = 0.038) and alpha (p = 0.039) bands and to bone pain in the alpha band (p = 0.0092). Hence, MVPA of multi-channel EEG was able to identify frequency bands and corresponding channels most sensitive to altered brain activity during remifentanil treatment. As the EEG alterations were correlated to the analgesic effect, the approach may prove to be a novel methodology for monitoring individual efficacy to opioids.

U2 - 10.1111/bcpt.12330

DO - 10.1111/bcpt.12330

M3 - Journal article

C2 - 25250670

VL - 116

SP - 414

EP - 422

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 5

ER -

ID: 129173842